drugset / Trial / NCT04828083

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

NCT04828083 ↗

Phase 4 Completed 120 enrolled Rhode Island Hospital
RandomizedParallel-groupTriple-blindSupportive care

Summary

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

Timeline

Start
2021-03-01
Primary completion
2024-08-30
Completion
2024-09-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications